GRI

GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference

Retrieved on: 
Thursday, March 28, 2024
GRI, Natural killer T cell, NKT, Conference, Doctor of Philosophy

LA JOLLA, CA, March 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that Marc Hertz, PhD, Chief Executive Officer of GRI Bio, will present at the MedInvest Biotech & Pharma Investor Conference being held in New York City, NY on Wednesday, April 3, 2024 at 10:10 AM ET.

Key Points: 
  • LA JOLLA, CA, March 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that Marc Hertz, PhD, Chief Executive Officer of GRI Bio, will present at the MedInvest Biotech & Pharma Investor Conference being held in New York City, NY on Wednesday, April 3, 2024 at 10:10 AM ET.
  • In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference.
  • For more information about the conference, please visit the conference website .

G&A INSTITUTE ANNOUNCES 2024 PATHFINDER WEBINAR SERIES: Navigating the New Regulatory Environment for Corporate Sustainability Disclosures

Retrieved on: 
Wednesday, March 27, 2024
ERM, Risk management, Accounting, Knowledge, Research, ISSB, G&A, COSO, ICSR, GRI, CSRD, Legislation, JD, CPA, Renewable energy

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) --  Governance & Accountability Institute, Inc. (G&A), a leader in corporate sustainability consulting and research, is pleased to announce its 2024 Pathfinder Webinar Series.

Key Points: 
  • NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) --  Governance & Accountability Institute, Inc. (G&A), a leader in corporate sustainability consulting and research, is pleased to announce its 2024 Pathfinder Webinar Series.
  • Participants will dive into an ocean of knowledge, with the G&A team and guest experts helping to demystify the shifting tides of sustainability reporting and regulatory compliance.
  • The Pathfinder Webinar Series is designed to inform and empower corporate reporters with the knowledge and tools needed to navigate the increasingly complex landscape of both domestic and international sustainability reporting.
  • G&A invites you to join us on this journey through the new regulatory environment for sustainability disclosures.

Energy Vault Issues 2023 Sustainability Report

Retrieved on: 
Monday, April 8, 2024
Other Energy, Environment, Utilities, Sustainability, Alternative Energy, Energy, CSA, S&P Global, Science Based Targets initiative, Energy Vault, Corporate sustainability, Biophysical environment, Risk, ESG, Strategic planning, Science, United Nations Global Compact, Carbon, GRI, TCFD, Task force, Multimedia, Targets, Renewable energy

Energy Vault Holdings, Inc. (NYSE: NRGV) ("Energy Vault" or the “Company”), a leader in sustainable, grid-scale energy storage solutions, today announced the publication of its 2023 Sustainability Report .

Key Points: 
  • Energy Vault Holdings, Inc. (NYSE: NRGV) ("Energy Vault" or the “Company”), a leader in sustainable, grid-scale energy storage solutions, today announced the publication of its 2023 Sustainability Report .
  • View the full release here: https://www.businesswire.com/news/home/20240408193128/en/
    Energy Vault Issues 2023 Sustainability Report (Photo: Business Wire)
    The report demonstrates Energy Vault’s commitment to providing transparency and progress on material non-financial sustainability & Environmental, Social, and Governance metrics.
  • In its second annual Corporate Sustainability Report, Energy Vault shares early-stage data and 2023 activations of newly established sustainability infrastructure, systems, protocols, standards, and metrics from which the organization measures current and future success.
  • “As the business continues to grow and evolve to meet the growing demand for tailored energy storage solutions around the globe, I’m confident in our ability to continue to progress toward and ultimately achieve our sustainability goals moving forward.”
    Energy Vault invites all of its stakeholders across the world to read its 2023 Sustainability Report at the following link: Sustainability Report 2023

Q2 TD Cowen/AFS Freight Index: Parcel surcharge changes wring out additional revenue, LTL and truckload rates hold steady

Retrieved on: 
Tuesday, April 9, 2024
DAS, AFS, LTL, Transport, GRI, ZIP, FedEx, Yoy, Index, Quarter, UPS, Cargo

ATLANTA, April 9, 2024 /PRNewswire/ -- AFS Logistics, an industry-leading third-party logistics (3PL) provider, and TD Cowen announce the second quarter (Q2) 2024 release of the TD Cowen/AFS Freight Index, a snapshot with predictive pricing for truckload, less-than-truckload (LTL) and parcel transportation markets. The latest release of the index expects LTL and truckload rates to remain steady, consistent with trends established since Q2 of last year. In parcel, the index shows the effect of fuel surcharge increases and other accessorial changes to drive net rate growth in Q1 and Q2 2024, despite limited overall demand.

Key Points: 
  • The latest release of the index expects LTL and truckload rates to remain steady, consistent with trends established since Q2 of last year.
  • In parcel, the index shows the effect of fuel surcharge increases and other accessorial changes to drive net rate growth in Q1 and Q2 2024, despite limited overall demand.
  • "While truckload and LTL markets are largely a continuation of established trends, parcel carriers have unleashed a wave of key pricing changes to raise revenue," says Tom Nightingale, CEO of AFS.
  • The ground parcel fuel surcharge is based on the U.S. on-highway diesel fuel index , and express is based on the U.S. Gulf Coast kerosene-type jet fuel .

Glen Boehm, CCIM From Boehm Commercial Group Secures #1 Keller Williams Commercial Agent in Texas

Retrieved on: 
Monday, April 8, 2024
GRI, Organization, Marketing, Boehm, CCIM, Property management

BOERNE, Texas, April 8, 2024 /PRNewswire/ -- In the competitive landscape of Texas commercial real estate, Glen Boehm, CCIM of Boehm Commercial Group stands out as a leading force, achieving the remarkable feat of being named the #1 Keller Williams Commercial Agent in Texas for the second year in a row.

Key Points: 
  • BOERNE, Texas, April 8, 2024 /PRNewswire/ -- In the competitive landscape of Texas commercial real estate, Glen Boehm, CCIM of Boehm Commercial Group stands out as a leading force, achieving the remarkable feat of being named the #1 Keller Williams Commercial Agent in Texas for the second year in a row.
  • This accolade, celebrated at the prestigious Keller Williams awards ceremony on February 16th, 2024 solidifies Boehm's reputation as a trusted and high-performing commercial real estate agent in Texas.
  • With decades of experience exclusively in the commercial real estate sector, Boehm and the Boehm Commercial Group have built a team with unparalleled expertise and a relentless dedication to delivering exceptional results.
  • Glen Boehm, CCIM, the driving force behind Boehm Commercial Group, has been a licensed real estate agent for nearly two decades, with the past 10 years dedicated to Keller Williams Commercial.

Constellium Releases 2023 Sustainability Report

Retrieved on: 
Wednesday, March 20, 2024
Carbon, Community, Electricity, CDP, Carbon Disclosure Project, Climate change, Woman, Environment, Recycling, GHG, CSTM, Light, Neuf-Brisach, GRI, Safety, Sustainability, Platinum, Constellium, Commercial code, AA

PARIS, March 20, 2024 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) today announced the release of its 2023 Sustainability Report.

Key Points: 
  • PARIS, March 20, 2024 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) today announced the release of its 2023 Sustainability Report.
  • “Constellium has continued to make strides in its sustainability journey, despite a challenging environment and the continued impact of the energy crisis in Europe”, said Jean-Marc Germain, CEO of Constellium.
  • The report details Constellium’s sustainability performance in 2023, including:
    Safety: We delivered best-in-class safety performance in 2023, with a recordable case rate of 1.95 per million hours worked vs. a target of 1.5 in 2025, a slight increase vs. our 2022 results of 1.85.
  • Constellium’s 2023 Sustainability Report details the company's initiatives and results and is organized and presented in accordance with the Global Reporting Initiative’s (GRI) Sustainability Reporting Standards.

GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators

Retrieved on: 
Thursday, March 14, 2024
Retinoic acid, Patient, CIPO, Doctor of Philosophy, Idiopathic pulmonary fibrosis, GRI, IPF, RAR, Treatment, Oxygen, Patent, Interim, NKT, Idiopathic disease, Liver, Movement, Natural killer T cell, Pharmaceutical industry

LA JOLLA, CA, March 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for Patent Application No. 3,007,970 titled, "Prevention and Treatment of Inflammatory Conditions." A patent from the recently allowed application is expected to be issued in the coming months.

Key Points: 
  • A patent from the recently allowed application is expected to be issued in the coming months.
  • “We have remained committed to bolstering our intellectual property protection across our innovative pipeline of NKT cell modulators.
  • IPF is a rare chronic progressive pulmonary disease with abnormal scarring of the lung blocking the movement of oxygen into the bloodstream.
  • For more information about the Company’s innovative pipeline of NKT cell regulators for the treatment of inflammatory, fibrotic and autoimmune diseases, visit gribio.com .

Philip Morris International Demonstrates Clear Progress Toward Its Purpose as It Releases 2023 Integrated Report

Retrieved on: 
Thursday, March 28, 2024
Sustainability, Environment, Environmental, Social and Governance (ESG), Tobacco, Professional Services, Consumer, Other Consumer, Retail, Smoke, Philip Morris International, Integration, Materiality, History, Sale, Child, Science, Quality of life, GRI, Intellectual property, United Nations Global Compact, Marketing, Dow Jones, Science Based Targets initiative, FLAG, Information, Woman, ISS, Privacy, Food, Prevalence, ESG, PMI, Research, Classification, Heated tobacco product, Investment, Dow Jones Sustainability Indices, Targets, Farmer, COVID-19, Life, ZYN, Biodiversity, Smoking, Water, IQOS, Toxicology, World Bank

Please visit pmi.com/sustainability to learn more, and read the full 2023 Integrated Report , case studies and market stories , and the Sustainability KPI Protocol 2023 .

Key Points: 
  • Please visit pmi.com/sustainability to learn more, and read the full 2023 Integrated Report , case studies and market stories , and the Sustainability KPI Protocol 2023 .
  • 2 For definition of net revenues related to smoke-free products, see Glossary available on pages 208-212 of PMI Integrated Report 2023.
  • 3 For definition of available for sale, see Glossary available on pages 208-212 of PMI Integrated Report 2023.
  • For definition of low- and middle-income markets, see Glossary available on pages 208-212 of PMI Integrated Report 2023.

Fastenal Releases 2024 Environmental, Social, and Governance (ESG) Report

Retrieved on: 
Thursday, March 28, 2024
Machinery, Professional Services, Machine Tools, Metalworking & Metallurgy, Recycling, Sustainability, Other Construction & Property, Construction & Property, Environment, Chemicals, Plastics, Transport, Logistics, Supply Chain Management, Environmental, Social and Governance (ESG), Manufacturing, Health, Organization, Silver, EMR, ESG, National Council, Disclosure, Carbon, GRI, Sustainability accounting, TCFD, Compensation, Creativity, Task force, Management

Fastenal Company (Nasdaq: FAST) is proud to announce the publication of its 2024 ESG Report.

Key Points: 
  • Fastenal Company (Nasdaq: FAST) is proud to announce the publication of its 2024 ESG Report.
  • A consistent theme of the report is how Fastenal's 23,000-plus employees are using their talents and creativity to advance the company's ESG vision: empowering people, preserving our world, and serving as a trusted partner.
  • Their efforts, combined with an organizational commitment to continuously improve processes, systems, and reporting, helped Fastenal solidify and make progress toward its long-term ESG goals in 2023.
  • "We're excited to share our story in this latest ESG report."

Charles River Laboratories Publishes 2023 Corporate Citizenship Report

Retrieved on: 
Wednesday, March 27, 2024
Stem Cells, Biotechnology, FDA, Professional Services, Health, General Health, Pharmaceutical, Environmental, Social and Governance (ESG), Medical Devices, Research, Science, Erg, Electricity, Certification, Integrity, Learning, ISMS, Biophysical environment, GHG, ESG, Patient, CRL, Refinement, GRI, Woman, Social, Responsibility, Sustainability accounting, TCFD, Task force, Corporate social responsibility, ISO, Food, Animal, Pharmaceutical industry

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2023 Corporate Citizenship Report , which includes progress and results from 2022 and 2023.

Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2023 Corporate Citizenship Report , which includes progress and results from 2022 and 2023.
  • The 2023 report demonstrates Charles River’s priorities and commitments across its strategic Environmental, Social and Governance (ESG) areas of focus: Accelerate Life-Saving Therapies; Lead with Integrity; Inspire our People; and Protect our Planet.
  • The 2023 Corporate Citizenship Report was prepared in accordance with the latest Global Reporting Initiative (GRI) Universal Standards, as well as the Sustainability Accounting Standards Board (SASB) Biotechnology and Pharmaceuticals Standard.
  • Visit the Corporate Citizenship section of Charles River’s website to read the 2023 Corporate Citizenship Report in its entirety and learn more about the Company’s ESG disclosures.